NasdaqGM:TNDMMedical Equipment
Did t:slim X2 Legal Probe Just Shift Tandem Diabetes Care's (TNDM) Disclosure and Risk Narrative?
Tandem Diabetes Care, Inc. previously announced that management would provide company updates at several investor conferences in early 2026, with live and archived webcasts available via its Investor Center.
More recently, The Rosen Law Firm began investigating potential securities claims tied to Tandem’s voluntary medical device correction for certain t:slim X2 insulin pumps, raising fresh legal and reputational questions around its disclosure practices.
We’ll now examine how the...